Efficacy and safety of afuresertib plus paclitaxel versus paclitaxel in patients with platinum-resistant ovarian cancer: An open-label randomized active-controlled phase II clinical study (GOG-3044)

IF 4.1 2区医学 Q1 OBSTETRICS & GYNECOLOGY

Gynecologic oncology Pub Date : 2025-09-01 DOI:10.1016/j.ygyno.2025.03.059

Thomas Herzog , David O'Malley , John Liao , Karen Finkelstein , Lyndsay Willmott , John Moroney , Joseph Buscema , Katie Campbell-Simms , Susan Zweizig

引用次数: 0

查看原文本刊更多论文

afuresertib联合紫杉醇与紫杉醇治疗铂耐药卵巢癌的疗效和安全性：开放标签随机主动对照II期临床研究（GOG-3044）

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Gynecologic oncology 医学-妇产科学

CiteScore

8.60

自引率

6.40%

发文量

1062

审稿时长

37 days

期刊介绍： Gynecologic Oncology, an international journal, is devoted to the publication of clinical and investigative articles that concern tumors of the female reproductive tract. Investigations relating to the etiology, diagnosis, and treatment of female cancers, as well as research from any of the disciplines related to this field of interest, are published. Research Areas Include: • Cell and molecular biology • Chemotherapy • Cytology • Endocrinology • Epidemiology • Genetics • Gynecologic surgery • Immunology • Pathology • Radiotherapy